This work was funded by P20GM10344 and R01AI139248 awarded to Z. D. Dalebroux.

1. General Reagents and Media Preparation for Membrane Extraction
<ol>
	<li>Bacterial growth media: Prepare and sterilize 1 L of broth media in a thoroughly cleaned and autoclaved 2 L flask.</li>
	<li>General resuspension buffer (1 M Tris Buffer pH 7.5; 50 mL): Dissolve 6.05 g of Tris base in 30 mL of H2O. Adjust pH to 7.5 with 5 M HCl. Adjust final volume to 50 mL with ultrapure H2O.</li>
	<li>Master stock of divalent cation chelation solution (0.5 M EDTA pH 8; 100 mL): Add 18.6 g of disodium ethylene tetraacetate&#183;2H2O to 80 mL of H2O. Stir vigorously and adjust pH to 8.0 with NaOH. Adjust final volume to 100 mL with ultrapure H2O. 
	NOTE: The disodium salt of EDTA will not dissolve until the pH of the solution is adjusted to ~8.0 by the addition of NaOH.</li>
	<li>Osmotic buffer A (0.5 M sucrose, 10 mM Tris pH 7.5; 1 L): Weigh 171.15 g of sucrose and transfer to a 1 L cylinder. Add 10 mL of 1 M Tris pH 7.5. Adjust to a final volume of 1 L with ultrapure H2O. Store at 4 &#176;C.</li>
	<li>Lysozyme (10 mg/mL; 5 mL): Weigh 50 mg of (chicken egg-white) lysozyme and dissolve in 5 mL ultrapure H2O. Store at 4 &#176;C.</li>
	<li>Diluted divalent cation chelation solution (1.5 mM EDTA; 500 mL): Add 1.5 mL of 0.5 M EDTA (Step 1.3) to 497.5 mL ultrapure H2O. Store at 4 &#176;C.</li>
	<li>Osmotic buffer B (0.2 M sucrose, 10 mM Tris pH 7.5; 2 L): Weigh 136.8 g of sucrose and transfer to a 2 L cylinder. Add 20 mL of 1 M Tris pH 7.5. Adjust final volume to 2 L with ultrapure H2O. Store at 4 &#176;C.</li>
	<li>Nuclease co-factor (1 M MgCl2; 10 mL): Dissolve 2.03 g of MgCl2&#183;6H2O in 8 mL of ultrapure H2O. Adjust volume to 10 mL. Store at room temperature.</li>
	<li>Nuclease solution cocktail including RNase and DNase enzymes: See Table of Materials. Store at -20 &#176;C.</li>
	<li>Protease inhibitor cocktail: See Table of Materials. Store at 4 &#176;C.</li>
	<li>Low-density isopycnic sucrose gradient solution (20% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5 Solution; 100 mL): Weigh 20 g of sucrose and transfer to a 200 mL cylinder. Add 100 &#181;L of 1 M Tris Buffer pH 7.5 and 200 &#181;L of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H2O. Store at room temperature.</li>
	<li>Medium-density isopycnic sucrose gradient solution (53% w/v sucrose, 1 mM EDTA, 1mM Tris pH 7.5 Solution; 100 mL): Weigh 53 g of sucrose and transfer to a 200 mL graduated cylinder. Add 100 &#181;L of 1 M Tris Buffer pH 7.5 and 200 &#181;L of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H2O. Store at room temperature. 
	NOTE: Prepare this solution in a graduated cylinder to ensure accuracy due to the high percentage of sucrose. Add a magnetic stir bar and stir until the sucrose is completely dissolved in solution. This process may take several hours.</li>
	<li>High-density isopycnic sucrose gradient solution (73% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5 Solution; 100 mL): Weigh 73 g of sucrose and transfer to a 200 mL graduated cylinder. Add 100 &#181;L of 1 M Tris Buffer pH 7.5 and 200 &#181;L of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H2O. Store at room temperature. 
	NOTE: Prepare this solution in a graduated cylinder to ensure accuracy due to the high percentage of sucrose. Add a magnetic stir bar and stir until the sucrose is completely dissolved. This process may take several hours.</li>
	<li>Isolated-membrane-storage buffer (10 mM Tris Buffer pH 7.5; 1 L): Add 1 mL of 1 M Tris Buffer pH 7.5 to a 1 L flask and adjust the final volume to 1 L with ultrapure H2O.</li>
	<li>&#946;-Nicotinamide adenine dinucleotide (NADH) (10 mg/mL solution): Resuspend 10 mg of NADH in ultrapure H2O. Prepare fresh stocks, weekly. Store at -20 &#176;C.</li>
	<li>Phenol solution equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA: See Table of Materials. Store the solution at 4 &#176;C.</li>
	<li>Lipopolysaccharide gel stain kit: See Table of Materials.</li>
	<li>Bradford reagent: See Table of Materials. 
	NOTE: All solutions and media should be prepared within the week of performing the assay to ensure consistent results.</li>
</ol>
2. Preparation of Bacteria for Membrane Extraction
<ol>
	<li>Streak the bacteria from frozen glycerol stocks onto fresh agar plates. Store the plates at 4 &#176;C once colonies develop. Inoculate a single colony into a 5 mL tube filled with broth media and culture the bacteria as desired overnight.</li>
	<li>Back-dilute the overnight bacterial culture into 1 L of preferred broth media and culture the bacteria until the desired optical density is achieved. 
	NOTE: Inoculating a single bacterial colony into 1 L of broth media is recommended for mutant genotypes that are prone to suppressing growth phenotypes, but some Gram-negative bacteria simply grow slower than others. If it is not possible to achieve a sufficient culture density by single-colony inoculation, back diluting an overnight culture into 1 L of media is one strategy to synchronize growth. Bacterial-membrane composition varies depending upon the growth phase of the culture (logarithmic vs stationary phase)13. Growth curves measuring the change in optical density for the bacterial cultures as a function of time should be performed with all strains to correlate culture density with growth phase.</li>
	<li>Set the flasks containing the broth cultures on ice. Read the optical density at 600 nm (OD600) and calculate the volume of culture that is equivalent to between 6.0 and 8.0 x 1011 bacterial colony forming units (cfu). For S. Typhimurium, this corresponds to 1 L of culture at an OD600 of between 0.6-0.8, since an OD600 of 1.0 is equal to roughly 1.0x109 cfu/mL. Add this volume to a centrifuge tube and ensure that the remaining cultures stay on ice until they are to be used.</li>
	<li>Pellet the bacteria by centrifugation at 4 &#176;C at 7,000-10,000 x g in a fixed angle high-speed centrifuge for 10 min. 
	NOTE: Pre-cool and maintain the centrifuges at a low temperature. Maintain the samples on ice during the entire procedure.</li>
	<li>Decant and discard the supernatant carefully. 
	NOTE: The pellet can be flash frozen and/or stored at -80 &#176;C if the membrane fractions are not going to be extracted immediately. However, it is recommended to proceed directly with plasmolysis on the same day the cells are harvested, and is especially recommended for non-enterobacterial species.</li>
</ol>
3. Dissociation of the Outer Membrane and Plasmolysis
<ol>
	<li>Thaw the cell pellets on ice if previously stored at -80 &#176;C and retain the samples on ice for the remainder of the procedure. Resuspend each cell pellet within the centrifuge tube in 12.5 mL of buffer A. Add a magnetic stir bar to the suspension of cells.</li>
	<li>Add 180 &#181;L of 10 mg/mL lysozyme (final concentration of 144 &#956;g/mL) to each cell resuspension. Keep the samples on ice while stirring for 2 min.</li>
	<li>Add 12.5 mL of 1.5 mM EDTA solution to each cell resuspension and continue stirring on ice for an additional 7 min.</li>
	<li>Decant the suspension into a 50 mL conical tube and centrifuge at 9,000-11,000 x g for 10 min at 4 &#176;C.</li>
	<li>Discard supernatants into a biohazard waste container and retain the pellets on ice.</li>
	<li>Add 25 mL of buffer B to the cell pellet.</li>
	<li>Add 55 &#181;L of 1 M MgCl2, 1 &#181;L of RNase/DNase nuclease reagent (to avoid viscosity problems associated with bacteria undergoing plasmolysis prior to homogenization), and 1 &#181;L of protease inhibitor cocktail to the volume of buffer B that sits atop the cell pellet</li>
	<li>Resuspend the pellet in the buffer B mixture. Vigorously pipet and vortex until observing a homogenous solution. 
	NOTE: It is very important to have a homogenous solution before proceeding to Step 4 of this protocol. The resuspended cells should have a viscous cake-batter like appearance and consistency.</li>
	<li>Vortex each sample for 15 s. Retain suspensions on ice and proceed to Step 4.</li>
</ol>
4. Pressurized Homogenization and Lysis
NOTE: Several methods can be used for lysis. Sonication is not ideal due to the generation of heat. Osmotic lysis can be achieved but is often inefficient. Therefore, we recommend high-pressure lysis. High pressure lysis can be achieved using a variety of instruments. We suggest homogenization machines, such as the French Press or the Emusliflex. We work with many types of Gram-negative bacteria whose response to high osmolar sucrose solutions varies. The high-pressure homogenization step improves efficiency, reproducibility, and yield.
<ol>
	<li>Prechill the French Press cell at 4 &#176;C or insert the metal coil from the homogenizer machine on ice.</li>
	<li>Pour the sample into the French-pressure cell or the homogenizer-sample cylinder and bring the cell under the desired homogenization pressure (10,000 psi should be adequate when using a French Press or 20,000 psi when using a homogenizer).</li>
	<li>Adjust the outlet flow rate to approximately one drop per second while maintaining the pressure if utilizing a French Press.</li>
	<li>Collect the cell lysate in 50 mL conical tubes while keeping samples on ice.</li>
	<li>Repeat steps 4.2-4.4 three to five times to achieve complete lysis, typically indicated by gradual increase in transparency of sample. 
	NOTE: The sample chamber should be washed and equilibrated with Buffer B in between samples.</li>
	<li>Keep lysed cells on ice.</li>
</ol>
5. Total Membrane Fractionation
<ol>
	<li>Centrifuge the lysed bacterial samples at 6,169 x g for 10 min at 4 &#176;C to pellet remaining intact cell material. (e.g., unlysed bacterial cells).</li>
	<li>Distribute the remaining portion of the supernatant, which now contains the homogenized membranes into a polycarbonate bottle for ultracentrifugation. 
	CAUTION: If needed, cell samples can be balanced by diluting with buffer B.</li>
	<li>Ultracentrifuge the cell lysates at 184,500 x g for at least 1 h, at 4 &#176;C. This step can be performed overnight without affecting the quality of the membranes.</li>
	<li>Discard remaining supernatant present in the ultracentrifuge tube and retain membrane pellets on ice (Figure 1).</li>
	<li>Resuspend the membrane pellets in 1 mL of the low-density isopycnic-sucrose gradient solution using a glass-dounce homogenizer. Use a glass Pasteur pipette to transfer the sample homogenate to a 1.5 mL microcentrifuge tube and retain on ice. 
	NOTE: If only total membrane composition analysis is desired, substitute 1 mL of low-density isopycnic-sucrose gradient solution for 1 mL of isolated-membrane storage buffer. Step 5.5 is the endpoint of isolation if only total-bacterial membrane samples are desired. Store samples at -20 &#176;C until further downstream analysis is required.</li>
</ol>
6. Density Gradient Ultracentrifugation to Separate the Dual Membranes
<ol>
	<li>Gather the appropriate number of 13 mL polypropylene or ultra-clear open-top tubes specified for a swinging bucket rotor and ultracentrifuge.</li>
	<li>Hold the tube in a slightly tilted position and prepare the sucrose gradient by slowly adding sucrose solutions from higher density to lower density in the following order: 
	2 mL of 73% w/v sucrose,1 mM EDTA, 1 mM Tris pH 7.5 
	4 mL of 53% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5
	<ol>
		<li>Next, add the total membrane fraction (1 mL), which has been resuspended in the 20% w/v sucrose solution (step 5.5). Avoid mixing the membrane fraction with the sucrose solution that lies beneath it. Divisions should be visible between each of these layers.</li>
		<li>Finally, fill the tube with the low-density isopycnic-sucrose gradient solution (approx. 6 mL). Polypropylene and ultra-clear open-top tubes should be filled as full as possible (2 or 3 mm from the tube top) for tube support.</li>
	</ol>
	</li>
	<li>Adjustment for Acinetobacter baumannii 17978
	<ol>
		<li>Adapt an adjusted sucrose gradient for use with different bacterial specimens. For A. baumannii, the following sucrose gradient afforded more complete separation of the membranes (Figure 2). 
		2 mL of 73% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5 
		4 mL of 45% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5</li>
		<li>Next, add the total membrane fraction (1 mL), which has been resuspended in the 20% w/v sucrose solution (step 5.5). Avoid mixing the membrane fraction with the sucrose solution that lies beneath it. Divisions should be visible between each of these layers.</li>
		<li>Finally, fill the tube with low-density isopycnic-sucrose gradient solution (approx. 6 mL). Polypropylene and ultra-clear open-top tubes should be filled as full as possible (2 or 3 mm from the tube top) for tube support.</li>
	</ol>
	</li>
	<li>Ultracentrifuge the samples using a swinging-bucket rotor at 288,000 x g and 4 &#176;C overnight. 
	NOTE: For the volumes used in the previous steps, we recommend centrifugation times between 16 h and 23 h.</li>
	<li>Cut the end of a P1000 pipette tip about 5 mm from the point. Remove the upper-brown IM layer using the pipette. Transfer the IM fraction into a polycarbonate bottle for ultracentrifugation.</li>
	<li>Leave about 2 mL of the sucrose solution above the 53-73% interface to ensure that the lower white OM is not cross contaminated with the IM fraction. Repeat the pipetting procedure from step 6.4 for the OM fraction (Figure 1). 
	NOTE: The membranes can also be collected by puncturing the centrifuge tubes at the bottom using a needle and collecting the membranes as fractions dropwise.</li>
	<li>Fill the remaining void of the ultracentrifuge tube with isolated-membrane storage buffer and mix by inversion or pipetting. Retain the samples on ice.</li>
	<li>Collect the now washed and isolated membranes by ultracentrifugation at 184,500 x g for 1 h and 4 &#176;C.</li>
	<li>Discard the supernatant and resuspend the membranes by dounce-homogenization. Add 500-1000 &#956;L of storage buffer. Collect samples in 2 mL microcentrifuge tubes.</li>
	<li>Store the bacterial membrane samples at -20 &#176;C.</li>
</ol>
7. Confirming Separation of the Bilayers
NOTE: Incomplete separation of the bilayers can occur due to technical error or the unique cell envelope composition of some species. To confirm separation, we advise using two independent assays to quantify the degree of cross contamination between the bilayers. The first assay detects the enzymatic activity of NADH dehydrogenase, which exists exclusively in the IM. The second assay detects the presence of LOS or LPS, which predominantly exists in the OM.
<ol>
	<li>Confirming that the OMs are isolated from the IMs
	<ol>
		<li>Measure the protein concentration in each isolated membrane fraction using a Bradford protein assay.</li>
		<li>Add the volume of sample corresponding to between 50 and 500 &#181;g of protein to an empty 2 mL microcentrifuge tube. The concentration will vary depending upon the species, but 50 &#181;g is typically sufficient for Enterobacteriaceae. Add the appropriate volume of 10 mM Tris-buffer to achieve a total volume of 990 &#956;L. Transfer the content to a cuvette for spectrophotometry.</li>
		<li>Add 10 &#956;L of a 10 mg/mL solution of NADH to the sample and measure the initial absorbance at 340 nm.</li>
		<li>Continue measuring the absorbance every 30 s for 5 min.</li>
		<li>Compile the data and graph the change in absorbance (y-axis) vs. the change in time (x-axis) for each membrane fraction (Figure 3).</li>
	</ol>
	</li>
	<li>Confirming that the IMs are isolated from the OMs
	<ol>
		<li>Add the volume of sample corresponding to between 50 and 500 &#181;g of protein to an empty 2 mL microcentrifuge tube. The concentration will vary depending upon the bacterial species, but 50 &#181;g is typically sufficient for Enterobacteriaceae. Fill to a final volume of 100 &#956;L with phosphate buffered saline, which is hereafter referred to as the aqueous phase.</li>
		<li>Add 5 &#956;L of Proteinase K (stock 800 U/mL) to the aqueous phase and incubate overnight at 59 &#176;C.</li>
		<li>Warm a 10 mL aliquot of Tris-saturated Phenol for 10 min at 68 &#176;C.</li>
		<li>Spin down the aqueous phase samples that were treated with the Proteinase K and add the &#8220;hot&#8221; Tris-saturated Phenol at a 1:1 ratio with the aqueous phase, vortex vigorously and incubate at 68 &#176;C for 10 min.</li>
		<li>Transfer the now milky-white samples from 68 &#176;C to an ice-water bath and incubate for 10 min.</li>
		<li>Centrifuge the samples at 2,100 x g for 10 min at 4 &#176;C.</li>
		<li>Transfer the upper aqueous phase to a new tube and store the tube at -20 &#176;C if the sample is not to be used immediately.</li>
		<li>Dilute samples in SDS-loading buffer and load the wells of a 4-20% Tris-glycine gradient gel.</li>
		<li>Electrophorese for 45 min or until the dye-front is at the bottom of the gel.</li>
		<li>Stain the gel using the LPS staining kit following manufacturer&#8217;s instructions.</li>
	</ol>
	</li>
</ol>

<ol><li>Silhavy, T. J., Kahne, D., Walker, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+bacterial+cell+envelope%5BTitle%5D)+AND+%22Cold+Spring+Harbor+Perspectives+in+Biology%22%5BJournal%5D)">The bacterial cell envelope.</a> Cold Spring Harbor Perspectives in Biology. 2, 000414(2010).</li>
<li>Egan, A. J., Vollmer, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+physiology+of+bacterial+cell+division%5BTitle%5D)+AND+%22Annals+of+the+New+York+Academy+of+Sciences%22%5BJournal%5D)">The physiology of bacterial cell division.</a> Annals of the New York Academy of Sciences. 1277, 8-28 (2013).</li>
<li>Pazos, M., Peters, K., Vollmer, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Robust+peptidoglycan+growth+by+dynamic+and+variable+multi-protein+complexes%5BTitle%5D)+AND+%22Current+Opinion+in+Microbiology%22%5BJournal%5D)">Robust peptidoglycan growth by dynamic and variable multi-protein complexes.</a> Current Opinion in Microbiology. 36, 55-61 (2017).</li>
<li>Raetz, C. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Enzymology%2C+genetics%2C+and+regulation+of+membrane+phospholipid+synthesis+in+Escherichia+coli%5BTitle%5D)+AND+%22Clinical+Microbiology+Reviews%22%5BJournal%5D)">Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli.</a> Clinical Microbiology Reviews. 42, 614-659 (1978).</li>
<li>Whitfield, C., Trent, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Biosynthesis+and+export+of+bacterial+lipopolysaccharides%5BTitle%5D)+AND+%22Annual+Review+of+Biochemistry%22%5BJournal%5D)">Biosynthesis and export of bacterial lipopolysaccharides.</a> Annual Review of Biochemistry. 83, 99-128 (2014).</li>
<li>Needham, B. D., Trent, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fortifying+the+barrier%3A+the+impact+of+lipid+A+remodelling+on+bacterial+pathogenesis%5BTitle%5D)+AND+%22Nature+Reviews+Microbiology%22%5BJournal%5D)">Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.</a> Nature Reviews Microbiology. 11, 467-481 (2013).</li>
<li>Simpson, B. W., Trent, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pushing+the+envelope%3A+LPS+modifications+and+their+consequences%5BTitle%5D)+AND+%22Nature+Reviews+Microbiology%22%5BJournal%5D)">Pushing the envelope: LPS modifications and their consequences.</a> Nature Reviews Microbiology. 17, 403-416 (2019).</li>
<li>Ebbensgaard, A., Mordhorst, H., Aarestrup, F. M., Hansen, E. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Role+of+Outer+Membrane+Proteins+and+Lipopolysaccharides+for+the+Sensitivity+of+Escherichia+coli+to+Antimicrobial+Peptides%5BTitle%5D)+AND+%22Frontiers+in+Microbiology%22%5BJournal%5D)">The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides.</a> Frontiers in Microbiology. 9, 2153(2018).</li>
<li>Liu, D., Reeves, P. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Escherichia+coli+K12+regains+its+O+antigen%5BTitle%5D)+AND+%22Microbiology%22%5BJournal%5D)">Escherichia coli K12 regains its O antigen.</a> Microbiology. 140 (1), 49-57 (1994).</li>
<li>Kalynych, S., Morona, R., Cygler, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Progress+in+understanding+the+assembly+process+of+bacterial+O-antigen%5BTitle%5D)+AND+%22FEMS+Clinical+Microbiology+Reviews%22%5BJournal%5D)">Progress in understanding the assembly process of bacterial O-antigen.</a> FEMS Clinical Microbiology Reviews. 38, 1048-1065 (2014).</li>
<li>Osborn, M. J., Gander, J. E., Parisi, E., Carson, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanism+of+assembly+of+the+outer+membrane+of+Salmonella+typhimurium.+Isolation+and+characterization+of+cytoplasmic+and+outer+membrane%5BTitle%5D)+AND+%22Journal+of+Biological+Chemistry%22%5BJournal%5D)">Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane.</a> Journal of Biological Chemistry. 247, 3962-3972 (1972).</li>
<li>Osborn, M. J., Munson, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Separation+of+the+inner+%28cytoplasmic%29+and+outer+membranes+of+Gram-negative+bacteria%5BTitle%5D)+AND+%22Methods+in+Enzymology%22%5BJournal%5D)">Separation of the inner (cytoplasmic) and outer membranes of Gram-negative bacteria.</a> Methods in Enzymology. 31, 642-653 (1974).</li>
<li>Cian, M. B., Giordano, N. P., Masilamani, R., Minor, K. E., Dalebroux, Z. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Salmonella+enterica+serovar+Typhimurium+use+PbgA%2FYejM+to+regulate+lipopolysaccharide+assembly+during+bacteremia%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Salmonella enterica serovar Typhimurium use PbgA/YejM to regulate lipopolysaccharide assembly during bacteremia.</a> Infection and Immunity. , (2019).</li>
<li>Masilamani, R., Cian, M. B., Dalebroux, Z. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Salmonella+Tol-Pal+Reduces+Outer+Membrane+Glycerophospholipid+Levels+for+Envelope+Homeostasis+and+Survival+during+Bacteremia%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Salmonella Tol-Pal Reduces Outer Membrane Glycerophospholipid Levels for Envelope Homeostasis and Survival during Bacteremia.</a> Infection and Immunity. 86, (2018).</li>
<li>Nikaido, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Outer+Membrane+of+Salmonella-Typhimurium+Transmembrane+Diffusion+of+Some+Hydrophobic+Substances%5BTitle%5D)+AND+%22Biochimica+Et+Biophysica+Acta%22%5BJournal%5D)">Outer Membrane of Salmonella-Typhimurium Transmembrane Diffusion of Some Hydrophobic Substances.</a> Biochimica Et Biophysica Acta. 433, 118-132 (1976).</li>
<li>Dalebroux, Z. D., Matamouros, S., Whittington, D., Bishop, R. E., Miller, S. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((PhoPQ+regulates+acidic+glycerophospholipid+content+of+the+Salmonella+Typhimurium+outer+membrane%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane.</a> Proceedings of the National Academy of Sciences of the United States of America. 111, 1963-1968 (2014).</li>
<li>Castanie-Cornet, M. P., Cam, K., Jacq, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RcsF+is+an+outer+membrane+lipoprotein+involved+in+the+RcsCDB+phosphorelay+signaling+pathway+in+Escherichia+coli%5BTitle%5D)+AND+%22Journal+of+Bacteriology%22%5BJournal%5D)">RcsF is an outer membrane lipoprotein involved in the RcsCDB phosphorelay signaling pathway in Escherichia coli.</a> Journal of Bacteriology. 188, 4264-4270 (2006).</li>
<li>Thorne, K. J., Thornley, M. J., Glauert, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chemical+analysis+of+the+outer+membrane+and+other+layers+of+the+cell+envelope+of+Acinetobacter+sp%5BTitle%5D)+AND+%22Journal+of+Bacteriology%22%5BJournal%5D)">Chemical analysis of the outer membrane and other layers of the cell envelope of Acinetobacter sp.</a> Journal of Bacteriology. 116, 410-417 (1973).</li>
<li>Geisinger, E., Huo, W., Hernandez-Bird, J., Isberg, R. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Acinetobacter+baumannii%3A+Envelope+Determinants+That+Control+Drug+Resistance%2C+Virulence%2C+and+Surface+Variability%5BTitle%5D)+AND+%22Annual+Review+of+Microbiology%22%5BJournal%5D)">Acinetobacter baumannii: Envelope Determinants That Control Drug Resistance, Virulence, and Surface Variability.</a> Annual Review of Microbiology. 73, 481-506 (2019).</li>
<li>Kamischke, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Acinetobacter+baumannii+Mla+system+and+glycerophospholipid+transport+to+the+outer+membrane%5BTitle%5D)+AND+%22Elife%22%5BJournal%5D)">The Acinetobacter baumannii Mla system and glycerophospholipid transport to the outer membrane.</a> Elife. 8, (2019).</li>
</ol>

No conflicts of interest declared.

This method will continue to aid researchers in understanding the role of the cell envelope in bacterial physiology and pathogenesis. Following the sequential ultracentrifugation steps a purified total, inner, and OM fraction can be obtained. These membranes can be assayed in isolation to test hypotheses related to membrane protein localization and function, transport and trafficking across the periplasm, and the composition of the individual bilayers under various environmental conditions. Biological studies exploring t...

Gram-negative bacteria produce two membranes that are separated by a periplasmic space and a peptidoglycan cell wall1. The inner membrane (IM) encases the cytosol and is a symmetric bilayer of phospholipids. Peptidoglycan protects against turgor pressure and provides the bacterium with a cell shape, and is attached to the outer membrane (OM) by lipoproteins2,3. The OM surrounds the periplasm and is predominantly asymmetric. The inner leaflet consists of phospholipids and the outer leaflet consists of glycolipids known as lipooligosaccharides (LOS) or lipopolysaccharides (LPS)4,5. The lipid asymmetry and the biochemistry of the LOS/LPS molecules in the outer leaflet confer barrier properties to the cell surface that protect the bacterium against hazards in its environment6,7.
LPS molecules are comprised of three constituents: the lipid A disaccharolipid, the core oligosaccharide, and the O-polysaccharide or O-antigen. Lipid A is a multiply acylated disaccharolipid. Core-oligosaccharides consist of 10&#8211;15 sugars known as rough LPS or R-LPS. The core is subdivided into the inner region, composed of 2-keto-3-deoxy-D-manno-octulosonic acid (kdo) and one or more heptose residues, and an outer region that consists generally of hexoses (glucose or galactose) and heptoses, or acetamido sugars5. The outer core region is more variable in its components and structure than the inner core. In Salmonella spp., only one core structure has been described; however, in Escherichia coli there are five different core structures (designated K-12, R1, R2, R3, and R4)8. E. coli K-12 DH5&#945;, which we use in this procedure carries a mutation that results in production R-LPS9. The R-LPS molecules lack the O-antigen moiety and have a similar molecular weight to LOS molecules.
The addition of O-antigen to R-LPS turns this molecule into smooth LPS, or S-LPS. The O-antigens are built from short 3-4 carbohydrate subunits and consist of multiple modalities with varying chain lengths10. Some LPS-producing bacteria, like Salmonella enterica serovar Typhimurium (S. Typhimurium), display a trimodal distribution of LPS molecules on their surface10,11. Very-long chain O-antigens can contain over one hundred subunits and weigh over one hundred kilodaltons. The O-antigens provide surface properties to the bacterium that are necessary to resist antibiotics, evade predation by bacteriophages, and cause disease.
Species of Campylobacter, Bordetella, Acinetobacter, Haemophilus, Neisseria and others generate LOS molecules instead of LPS molecules on their surface12. LOS molecules consist of lipid A and core oligosaccharides but lack the O-antigen. These types of Gram-negative bacteria modify their core oligosaccharides with additional sugars and combinations of sugars to alter surface properties12. Both LOS and LPS-producing microbes derivatize the phosphates on lipid A and core molecules with cationic moieties7. These additions include phosphoethanolamine, galactosamine and aminoarabinose substitutions, which function by neutralizing anionic surface charge and thereby protecting against cationic antimicrobial peptides. Gram-negative bacteria also modify the core oligosaccharide structure with variable non-stoichiometric substitutions of sugars, or extra kdo molecules, and alter the number of acyl chains on lipid-A disaccharolipids7.
The ability to isolate the IM from the OM of Gram-negative bacteria has been instrumental for understanding the role of the cell envelope in antimicrobial resistance and disease pathogenesis11,12. Derivations of this approach have been used to deduce mechanisms of assembly, maintenance, and remodeling of the protein, phospholipid, and glycolipid constituents for the OM.
Our lab routinely performs bacterial lipidomic analyses to study protein-mediated lipid regulation and lipid function in a variety of Gram-negative species. The volumes used in the protocol reflect the routine use of this procedure to analyze non-radiolabeled phospholipids by thin layer chromatography and liquid chromatography tandem mass spectrometry13,14.
The protocol begins by exposing a chilled suspension of Gram-negative bacteria to a high osmolar solution of sucrose and adding lysozyme to dissociate the OM from the underlying peptidoglycan layer (Figure 1)12. EDTA is then added to facilitate penetration of the lysozyme, since divalent cation sequestration disrupts the lateral electrostatic bridging interactions between adjacent LOS/LPS molecules15. The original protocol from which ours has been adapted required the formation of spheroplasts, a Gram-negative bacterial cell form that consist of a plasma membrane and cytosol, but lacks the peptidoglycan layer and an OM. It is possible that spheroplasts are produced by the adapted method; however, the technique does not rely or intend on their formation for success. Instead, the lysozyme-EDTA treated bacteria are rapidly harvested by centrifugation and re-suspended in a sucrose solution of lesser concentration before pressurized lysis. The OMs that might have been released by forming spheroplasts should in theory be harvestable from the supernatants of the treated cells, but this approach is not detailed herein. Ultimately, the treated cells are subjected to conventional homogenization and lysis, which enhances the efficiency and reproducibility of the membrane separation procedure16.
After lysis, the total membranes are collected by ultracentrifugation and applied to a discontinuous sucrose density gradient to fractionate the IMs and OMs. The classical approach uses a more continuous gradient that consists of at least five different sucrose solutions11,12. The discontinuous gradient in our protocol consists of three sucrose solutions and partitions the bilayers into two distinct fractions17. The LOS and LPS molecules within the OMs of Gram-negative bacteria drive the envelope to partition into an upper brown low-density IM fraction and a lower white high-density OM fraction (Figure 1 and Figure 2).
Acinetobacter baumannii are important multidrug resistant human pathogens that produce LOS molecules in their OM and erect a cell envelope that is difficult to separate18,19. Recent work suggests that a derivation of the protocol we present here can be used to partition the bilayers of these organisms20. Therefore, we tested our protocol on A. baumannii 17978. Initially, the procedure was inadequate. However, we modified the sucrose concentration of the middle density solution and greatly improved separation (Figure 2). An NADH dehydrogenase assay and a LOS/LPS extraction and detection procedure was used to confirm separation for A. baumannii, wild-type S. Typhimurium and two O-antigen deficient enterobacterial genotypes; namely, galE-mutant S. Typhimurium and a laboratory strain, E. coli DH5&#945; (Figure 3 and Figure 4).
The intent of this work is to supply a streamlined approach for reproducibly isolating the membranes of Gram-negative bacteria. The protocol can be used to study many types of membrane-associated molecules for these microbes.

<table><tbody><tr><td>1 L Centrifuge bottles, PC/PPCO, super speed, with sealing cap, Nalgene</td><td>VWR</td><td>525-0466</td><td></td></tr><tr><td>1 L Pyrex Media Storage Bottle with High Temperature Cap</td><td>VWR</td><td>10416-312</td><td></td></tr><tr><td>2,000 mL Erlenmeyer Flask, Narrow Mouth</td><td>VWR</td><td>10545-844</td><td></td></tr><tr><td>4-20% mini PROTEAN Precast Protein Gels, 12 well</td><td>BIORAD</td><td>4561095</td><td></td></tr><tr><td>4x Laemmli Sample Buffer 10 mL</td><td>BIORAD</td><td>1610747</td><td></td></tr><tr><td>50 mL sterile polypropylene centrifuge tubes</td><td>VWR</td><td>89049-174</td><td></td></tr><tr><td>7 mL Dounce Tissue Homogenizer with Two Glass Pestles</td><td>VWR</td><td>71000-518</td><td></td></tr><tr><td>70 mL polycarbonate bottle assembly</td><td>Beckman Coulter Life Sciences</td><td>355622</td><td></td></tr><tr><td>Agar Powder</td><td>VWR</td><td>A10752</td><td></td></tr><tr><td>B10P Benchtop pH Meter with pH Probe</td><td>VWR</td><td>89231-664</td><td></td></tr><tr><td>Barnstead GenPure xCAD Plus UV/UF - TOC (bench version)</td><td>ThermoFisher Scientific</td><td>50136146</td><td></td></tr><tr><td>Benzonase Nuclease</td><td>MilliporeSigma</td><td>70746-3</td><td></td></tr><tr><td>EDTA disodium salt dihydrate 99.0-101.0%, crystals, ultrapure Bioreagent Molecular biology grade, J.T. Baker</td><td>VWR</td><td>4040-01</td><td></td></tr><tr><td>EmulsiFlex-C3</td><td>Avestin, Inc.</td><td></td><td></td></tr><tr><td>Fiberlite F13-14 x 50cy Fixed Angle Rotor</td><td>ThermoFisher Scientific</td><td>75006526</td><td></td></tr><tr><td>Hydrochloric acid 6.0 N</td><td>VWR</td><td>BDH7204</td><td></td></tr><tr><td>IBI Scientific Orbital Platform Shaker</td><td>Fischer Scientific</td><td>15-453-211</td><td></td></tr><tr><td>LB Broth Miller</td><td>VWR</td><td>214906</td><td></td></tr><tr><td>Lysozyme, Egg White, Ultra Pure Grade</td><td>VWR</td><td>VWRV0063</td><td></td></tr><tr><td>Magnesium chloride hexahydrate</td><td>Sigma Aldrich</td><td>M2670</td><td></td></tr><tr><td>NADH</td><td>Sigma Aldrich</td><td>10107735001</td><td></td></tr><tr><td>Optima XPN-80 - IVD</td><td>Beckman Coulter Life Sciences</td><td>A99839</td><td></td></tr><tr><td>Pharmco Products&amp;nbsp;PURE ALCOHOL 200 PROOF GL 4/CS&amp;nbsp;</td><td>Fischer Scientific</td><td>NC1624582</td><td></td></tr><tr><td>Phenol Solution, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, for molecular biology</td><td>Sigma - Millipore</td><td>P4557</td><td></td></tr><tr><td>Pierce Coomassie Plus (Bradford) Assay Kit</td><td>Thermofisher</td><td>23238</td><td></td></tr><tr><td>Pro-Q emerald 300 Lipopolysaccharide Gel Stain Kit</td><td>Thermofisher</td><td>P20495</td><td></td></tr><tr><td>Proteacease -50, EDTA free</td><td>G Biosciences</td><td>786-334</td><td></td></tr><tr><td>Proteinase K, Molecular Biology Grade</td><td>New England Biolabs</td><td>P8107S</td><td></td></tr><tr><td>Sodium hydroxide &amp;ge;99.99%</td><td>VWR</td><td>AA45780-22</td><td></td></tr><tr><td>Sorval RC 6 Plus Centrifuge</td><td>ThermoFisher Scientific</td><td>36-101-0816</td><td></td></tr><tr><td>Sucrose</td><td>MilliporeSigma</td><td>SX1075-3</td><td></td></tr><tr><td>SW 41 Ti Swinging-Bucket Rotor</td><td>Beckman Coulter Life Sciences</td><td>331362</td><td></td></tr><tr><td>Tris(hydroxymethyl)aminomethane (TRIS, Trometamol) &amp;ge;99.9% (dried basis), ultrapure Bioreagent Molecular biology grade, J.T. Baker</td><td>VWR</td><td>JT4109-6</td><td></td></tr><tr><td>Type 45 Ti Fixed-Angle Titanium Rotor</td><td>Beckman Coulter Life Sciences</td><td>339160</td><td></td></tr><tr><td>Ultra-Clear Tube ,14 x 89mm</td><td>Beckman Coulter Life Sciences</td><td>344059</td><td></td></tr><tr><td>Vortex-Genie 2</td><td>VWR</td><td>102091-234</td><td></td></tr></tbody></table>

separation of the cell envelope for gram-negative bacteria into inner and outer membrane fractions with technical adjustments for acinetobacter baumannii

This method works by partitioning the envelope of Gram-negative bacteria into total, inner, and outer membrane (OM) fractions and concludes with assays to assess the purity of the bilayers. The OM has an increased overall density compared to the inner membrane, largely due to the presence of lipooligosaccharides (LOS) and lipopolysaccharides (LPS) within the outer leaflet. LOS and LPS molecules are amphipathic glycolipids that have a similar structure, which consists of a lipid-A disaccharolipid and core-oligosaccharide substituent. However, only LPS molecules are decorated with a third subunit known as the O-polysaccharide, or O-antigen. The type and amount of glycolipids present will impact an organism&#8217;s OM density. Therefore, we tested whether the membranes of bacteria with varied glycolipid content could be similarly isolated using our technique. For the LPS-producing organisms, Salmonella enterica serovar Typhimurium and Escherichia coli, the membranes were easily isolated and the LPS O-antigen moiety did not impact bilayer partitioning. Acinetobacter baumannii produces LOS molecules, which have a similar mass to O-antigen deficient LPS molecules; however, the membranes of these microbes could not initially be separated. We reasoned that the OM of A. baumannii was less dense than that of Enterobacteriaceae, so the sucrose gradient was adjusted and the membranes were isolated. The technique can therefore be adapted and modified for use with other organisms.

This technique provides an effective means to isolate the IMs and OMs for Gram-negative bacteria. An outline of the entire procedure is illustrated (Figure 1). In general, the normalization of cultures to an OD600 of 0.6-0.8 in 1 L of media, or harvesting between 6.0 and 8.0 x 1011 bacterial cells will ensure that the appropriate amount of membrane material is collected for subsequent separation.
Upon lysing the bacteria and ultracentrifuging...

Watch this Scientific Journal Video about Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii at J

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Gram-negative bacteria produce two spatially segregated membranes. The outer membrane is partitioned from the inner membrane by a periplasm and a peptidoglycan layer. The ability to isolate the dual bilayers of these microbes has been critical for understanding their physiology and pathogenesis.

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

This method works by partitioning the envelope of Gram-negative bacteria into total, inner, and outer membrane (OM) fractions and concludes with assays to ...

separation-cell-envelope-for-gram-negative-bacteria-into-inner-outer

Research

Education

JoVE Core

JoVE Journal

Microbiology

Immunology and Infection

Unit

Microbial Cell Structure and Function        

SCIENTISTS IN ACTION

13.2K Views.  University of Oklahoma Health Sciences Center. Het bestuderen van hoe microben de chemische samenstelling van de individuele bilayers reguleren, zal onze kennis van mechanismen van antibioticadoden, antimicrobiële resistentie en ziektepathogenese informeren. Deze techniek partities de celenvelop van gram-negatieve bacteriën in twee gedefinieerde breuken zonder gebruik van wasmiddel. Daarom kunnen de lipiden, eiwitten en suikers worden beoordeeld in een omgeving die semi-native is.Sommige van de stappen zijn tijd afhankelijk en ve...

Video: Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Lipopolysaccharide (LPS) is the major cell surface molecule of gram-negative bacteria, deposited on the outer leaflet of the outer membrane bilayer. LPS can be subdivided into three domains: the distal O-polysaccharide, a core oligosaccharide, and the lipid A domain consisting of a lipid A molecular species and 3-deoxy-D-manno-oct-2-ulosonic acid residues (Kdo). The lipid A domain is the only component essential for bacterial cell survival. Following its synthesis, lipid A is chemically modified in response to environmental stresses such as pH or temperature, to promote resistance to antibiotic compounds, and to evade recognition by mediators of the host innate immune response. The following protocol details the small- and large-scale isolation of lipid A from gram-negative bacteria. Isolated material is then chemically characterized by thin layer chromatography (TLC) or mass-spectrometry (MS). In addition to matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) MS, we also describe tandem MS protocols for analyzing lipid A molecular species using electrospray ionization (ESI) coupled to collision induced dissociation (CID) and newly employed ultraviolet photodissociation (UVPD) methods. Our MS protocols allow for unequivocal determination of chemical structure, paramount to characterization of lipid A molecules that contain unique or novel chemical modifications. We also describe the radioisotopic labeling, and subsequent isolation, of lipid A from bacterial cells for analysis by TLC. Relative to MS-based protocols, TLC provides a more economical and rapid characterization method, but cannot be used to unambiguously assign lipid A chemical structures without the use of standards of known chemical structure. Over the last two decades isolation and characterization of lipid A has led to numerous exciting discoveries that have improved our understanding of the physiology of gram-negative bacteria, mechanisms of antibiotic resistance, the human innate immune response, and have provided many new targets in the development of antibacterial compounds.

Isolation and characterization of the lipid A domain of lipopolysaccharide (LPS) from gram-negative bacteria provides insight into cell surface based mechanisms of antibiotic resistance, bacterial survival and fitness, and how chemically diverse lipid A molecular species differentially modulate host innate immune responses.

Lipopolysaccharide (LPS) is the major cell surface molecule of gram-negative bacteria, deposited on the outer leaflet of the outer membrane bilayer. LPS ...

Chemistry

Isolation and Preparation of Bacterial Cell Walls for Compositional Analysis by Ultra Performance Liquid Chromatography

The bacterial cell wall is critical for the determination of cell shape during growth and division, and maintains the mechanical integrity of cells in the face of turgor pressures several atmospheres in magnitude. Across the diverse shapes and sizes of the bacterial kingdom, the cell wall is composed of peptidoglycan, a macromolecular network of sugar strands crosslinked by short peptides. Peptidoglycan&#8217;s central importance to bacterial physiology underlies its use as an antibiotic target and has motivated genetic, structural, and cell biological studies of how it is robustly assembled during growth and division. Nonetheless, extensive investigations are still required to fully characterize the key enzymatic activities in peptidoglycan synthesis and the chemical composition of bacterial cell walls. High Performance Liquid Chromatography (HPLC) is a powerful analytical method for quantifying differences in the chemical composition of the walls of bacteria grown under a variety of environmental and genetic conditions, but its throughput is often limited. Here, we present a straightforward procedure for the isolation and preparation of bacterial cell walls for biological analyses of peptidoglycan via HPLC and Ultra Performance Liquid Chromatography (UPLC), an extension of HPLC that utilizes pumps to deliver ultra-high pressures of up to 15,000 psi, compared with 6,000 psi for HPLC. In combination with the preparation of bacterial cell walls presented here, the low-volume sample injectors, detectors with high sampling rates, smaller sample volumes, and shorter run times of UPLC will enable high resolution and throughput for novel discoveries of peptidoglycan composition and fundamental bacterial cell biology in most biological laboratories with access to an ultracentrifuge and UPLC.

The bacterial cell wall is composed of peptidoglycan, a macromolecular network of sugar strands crosslinked by peptides. Ultra Performance Liquid Chromatography provides high resolution and throughput for novel discoveries of peptidoglycan composition. We present a procedure for the isolation of cell walls (sacculi) and their subsequent preparation for analysis via UPLC.

The bacterial cell wall is critical for the determination of cell shape during growth and division, and maintains the mechanical integrity of cells in the ...

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient

Capsule is a key virulence factor in many bacterial species, mediating immune evasion and resistance to various physical stresses. While many methods are available to quantify and compare capsule production between different strains or mutants, there is no widely used method for sorting bacteria based on how much capsule they produce. We have developed a method to separate bacteria by capsule amount, using a discontinuous density gradient. This method is used to compare capsule amounts semi-quantitatively between cultures, to isolate mutants with altered capsule production, and to purify capsulated bacteria from complex samples. This method can also be coupled with transposon-insertion sequencing to identify genes involved in capsule regulation. Here, the method is demonstrated in detail, including how to optimize the gradient conditions for a new bacterial species or strain, and how to construct and run the density gradient.

We demonstrate the use of discontinuous density gradients to separate bacterial populations based on capsule production. This method is used to compare capsule amount between cultures, isolate mutants with a specific capsule phenotype, or to identify capsule regulators. Described here is the optimization and running of the assay.

Capsule is a key virulence factor in many bacterial species, mediating immune evasion and resistance to various physical stresses. While many methods are ...

Genetics

Essential Metal Uptake in Gram-negative Bacteria: X-ray Fluorescence, Radioisotopes, and Cell Fractionation

We demonstrate a scalable method for the separation of the bacterial periplasm from the cytoplasm. This method is used to purify periplasmic protein for the purpose of biophysical characterization, and measure substrate transfer between periplasmic and cytoplasmic compartments. By carefully limiting the time that the periplasm is separated from the cytoplasm, the experimenter can extract the protein of interest and assay each compartment individually for substrate without carry-over contamination between compartments. The extracted protein from fractionation can then be further analyzed for three-dimensional structure determination or substrate-binding profiles. Alternatively, this method can be performed after incubation with a radiotracer to determine total percent uptake, as well as distribution of the tracer (and hence metal transport) across different bacterial compartments. Experimentation with a radiotracer can help differentiate between a physiological substrate and artefactual substrate, such as those caused by mismetallation.
X-ray fluorescence can be used to discover the presence or absence of metal incorporation in a sample, as well as measure changes that may occur in metal incorporation as a product of growth conditions, purification conditions, and/or crystallization conditions. X-ray fluorescence also provides a relative measure of abundance for each metal, which can be used to determine the best metal energy absorption peak to use for anomalous X-ray scattering data collection. Radiometal uptake can be used as a method to validate the physiological nature of a substrate detected by X-ray fluorescence, as well as support the discovery of novel substrates.

A protocol for the extraction of a periplasmic transition metal chaperone in the context of its native binding partners, and biophysical characterization of its substrate contents by X-ray fluorescence and radiometal uptake is presented.

We demonstrate a scalable method for the separation of the bacterial periplasm from the cytoplasm. This method is used to purify periplasmic protein for ...

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

Protein glycosylation is increasingly recognized as a common modification within bacterial organisms, contributing to prokaryotic physiology and optimal infectivity of pathogenic species. Due to this, there is increasing interest in characterizing bacterial glycosylation and a need for high-throughput analytical tools to identify these events. Although bottom-up proteomics readily enables the generation of rich glycopeptide data, the breadth and diversity of glycans observed in prokaryotic species make the identification of bacterial glycosylation events extremely challenging.
Traditionally, the manual determination of glycan compositions within bacterial proteomic datasets made this a largely bespoke analysis restricted to field-specific experts. Recently, open searching-based approaches have emerged as a powerful alternative for the identification of unknown modifications. By analyzing the frequency of unique modifications observed on peptide sequences, open searching techniques allow the identification of common glycans attached to peptides within complex samples. This article presents a streamlined workflow for the interpretation and analysis of glycoproteomic data, demonstrating how open searching techniques can be used to identify bacterial glycopeptides without prior knowledge of the glycan compositions.
Using this approach, glycopeptides within samples can rapidly be identified to understand glycosylation differences. Using Acinetobacter baumannii as a model, these approaches enable the comparison of glycan compositions between strains and the identification of novel glycoproteins. Taken together, this work demonstrates the versatility of open database-searching techniques for the identification of bacterial glycosylation, making the characterization of these highly diverse glycoproteomes easier than ever before.

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides

Open searching enables the identification of glycopeptides decorated with previously unknown glycan compositions. Within this article, a streamlined approach for undertaking open searching and subsequent glycan-focused glycopeptide searches are presented for bacterial samples using Acinetobacter baumannii as a model.

Protein glycosylation is increasingly recognized as a common modification within bacterial organisms, contributing to prokaryotic physiology and optimal ...

Biochemistry

Method for the Isolation of Francisella tularensis Outer Membranes

Francisella tularensis is a Gram-negative intracellular coccobacillus and the causative agent of the zoonotic disease tularemia. When compared with other bacterial pathogens, the extremely low infectious dose (&lt;10 CFU), rapid disease progression, and high morbidity and mortality rates suggest that the virulent strains of Francisella encode for novel virulence factors. Surface-exposed molecules, namely outer membrane proteins (OMPs), have been shown to promote bacterial host cell binding, entry, intracellular survival, virulence and immune evasion. The relevance for studying OMPs is further underscored by the fact that they can serve as protective vaccines against a number of bacterial diseases. Whereas OMPs can be extracted from gram-negative bacteria through bulk membrane extraction techniques, including sonication of cells followed by centrifugation and/or detergent extraction, these preparations are often contaminated with periplasmic and/or cytoplasmic (inner) membrane (IM) contaminants. For years, the "gold standard" method for the biochemical and biophysical separation of gram-negative IM and outer membranes (OM) has been to subject bacteria to spheroplasting and osmotic lysis, followed by sucrose density gradient centrifugation. Once layered on a sucrose gradient, OMs can be separated from IMs based on the differences in buoyant densities, believed to be predicated largely on the presence of lipopolysaccharide (LPS) in the OM. Here, we describe a rigorous and optimized method to extract, enrich, and isolate F. tularensis outer membranes and their associated OMPs.

Method for the Isolation of Francisella tularensis Outer Membranes

A protocol for separating inner and outer membranes from Francisella tularensis by spheroplasting, osmotic lysis, and sucrose density gradient ultracentrifugation.

Francisella tularensis is a Gram-negative intracellular coccobacillus and the causative agent of the zoonotic disease tularemia. When compared with other ...

Biology

Size Exclusion Chromatography to Analyze Bacterial Outer Membrane Vesicle Heterogeneity

The cell wall of Gram-negative bacteria consists of an inner (cytoplasmic) and outer membrane (OM), separated by a thin peptidoglycan layer. Throughout growth, the outer membrane can bleb to form spherical outer membrane vesicles (OMVs). These OMVs are involved in numerous cellular functions including cargo delivery to host cells and communication with bacterial cells. Recently, the therapeutic potential of OMVs has begun to be explored, including their use as vaccines and drug delivery vehicles. Although OMVs are derived from the OM, it has long been appreciated that the lipid and protein cargo of the OMV differs, often significantly, from that of the OM. More recently, evidence that bacteria can release multiple types of OMVs has been discovered, and evidence exists that size can impact the mechanism of their uptake by host cells. However, studies in this area are limited by difficulties in efficiently separating the heterogeneously sized OMVs. Density gradient centrifugation (DGC) has traditionally been used for this purpose; however, this technique is time-consuming and difficult to scale-up. Size exclusion chromatography (SEC), on the other hand, is less cumbersome and lends itself to the necessary future scale-up for therapeutic use of OMVs. Here, we describe a SEC approach that enables reproducible separation of heterogeneously sized vesicles, using as a test case, OMVs produced by Aggregatibacter actinomycetemcomitans, which range in diameter from less than 150 nm to greater than 350 nm. We demonstrate separation of &#34;large&#34; (350 nm) OMVs and &#34;small&#34; (&#60;150 nm) OMVs, verified by dynamic light scattering (DLS). We recommend SEC-based techniques over DGC-based techniques for separation of heterogeneously sized vesicles due to its ease of use, reproducibility (including user-to-user), and possibility for scale-up.

Bacterial vesicles play important roles in pathogenesis and have promising biotechnological applications. The heterogeneity of vesicles complicates analysis and use; therefore, a simple, reproducible method to separate varying sizes of vesicles is necessary. Here, we demonstrate the use of size exclusion chromatography to separate heterogeneous vesicles produced by Aggregatibacter actinomycetemcomitans.

The cell wall of Gram-negative bacteria consists of an inner (cytoplasmic) and outer membrane (OM), separated by a thin peptidoglycan layer. Throughout ...

Bioengineering

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

There is an emerging scientific need for reliable tools for monitoring membrane protein transport. We present a methodology leading to the reconstitution of efflux pumps from the Gram-negative bacteria Pseudomonas aeruginosa in a biomimetic environment that allows for an accurate investigation of their activity of transport. Three prerequisites are fulfilled: compartmentation in a lipidic environment, use of a relevant index for transport, and generation of a proton gradient. The membrane protein transporter is reconstituted into liposomes together with bacteriorhodopsin, a light-activated proton pump that generates a proton gradient that is robust as well as reversible and tunable. The activity of the protein is deduced from the pH variations occurring within the liposome, using pyranin, a pH-dependent fluorescent probe. We describe a step-by-step procedure where membrane protein purification, liposome formation, protein reconstitution, and transport analysis are addressed. Although they were specifically designed for an RND transporter, the described methods could potentially be adapted for use with any other membrane protein transporter energized by a proton gradient.

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

We present a protocol for the in vitro investigation of efflux pumps from Pseudomonas aeruginosa. This protocol allows for the generation of a robust, reversible, and tunable proton gradient within the liposome membrane and hence should be adaptable to any membrane protein energized by the protomotive force.

There is an emerging scientific need for reliable tools for monitoring membrane protein transport. We present a methodology leading to the reconstitution ...

Single&#45;Copy Gene Expression for Characterizing Multidrug Efflux Systems

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System

Acinetobacter baumannii is recognized as a challenging Gram-negative pathogen due to its widespread resistance to antibiotics. It is crucial to comprehend the mechanisms behind this resistance to design new and effective therapeutic options. Unfortunately, our ability to investigate these mechanisms in A. baumannii is hindered by the paucity of suitable genetic manipulation tools. Here, we describe methods for utilizing a chromosomal mini-Tn7-based system to achieve single-copy gene expression in an A. baumannii strain that lacks functional RND-type efflux mechanisms. Single-copy insertion and inducible efflux pump expression are quite advantageous, as the presence of RND efflux operons on high-copy number plasmids is often poorly tolerated by bacterial cells. Moreover, incorporating recombinant mini-Tn7 expression vectors into the chromosome of a surrogate A. baumannii host with increased efflux sensitivity helps circumvent interference from other efflux pumps. This system is valuable not only for investigating uncharacterized bacterial efflux pumps but also for assessing the effectiveness of potential inhibitors targeting these pumps.

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System

We describe a facile procedure for the single-copy chromosomal complementation of an efflux pump gene using a mini-Tn7-based expression system into an engineered efflux-deficient strain of Acinetobacter baumannii. This precise genetic tool allows for controlled gene expression, which is key for the characterization of efflux pumps in multidrug resistant pathogens.

Acinetobacter baumannii is recognized as a challenging Gram-negative pathogen due to its widespread resistance to antibiotics. It is crucial to comprehend ...

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Transposon sequencing (Tn-seq) is a powerful method that combines transposon mutagenesis and massive parallel sequencing to identify genes and pathways that contribute to bacterial fitness under a wide range of environmental conditions. Tn-seq applications are extensive and have not only enabled examination of genotype-phenotype relationships at an organism level but also at the population, community and systems levels. Gram-negative bacteria are highly associated with antimicrobial resistance phenotypes, which has increased incidents of antibiotic treatment failure. Antimicrobial resistance is defined as bacterial growth in the presence of otherwise lethal antibiotics. The &#8220;last-line&#8221; antimicrobial colistin is used to treat Gram-negative bacterial infections. However, several Gram-negative pathogens, including Acinetobacter baumannii can develop colistin resistance through a range of molecular mechanisms, some of which were characterized using Tn-seq. Furthermore, signal transduction pathways that regulate colistin resistance vary within Gram-negative bacteria. Here we propose an efficient method of transposon mutagenesis in A. baumannii that streamlines generation of a saturating transposon insertion library and amplicon library construction by eliminating the need for restriction enzymes, adapter ligation, and gel purification. The methods described herein will enable in-depth analysis of molecular determinants that contribute to A. baumannii fitness when challenged with colistin. The protocol is also applicable to other Gram-negative ESKAPE pathogens, which are primarily associated with drug resistant hospital-acquired infections.

We describe a method to generate saturating transposon mutant libraries in Gram-negative bacteria and subsequent preparation of DNA amplicon libraries for high-throughput sequencing. As an example, we focus on the ESKAPE pathogen, Acinetobacter baumannii, but this protocol is amenable to a wide range of Gram-negative organisms.

Transposon sequencing (Tn-seq) is a powerful method that combines transposon mutagenesis and massive parallel sequencing to identify genes and pathways ...

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Samenvatting

Meer video's verkennen